Company Information
USD
62.73
- (-2%)
NASDAQ:TECH, BIO-TECHNE CORPORATION
Industry: Biotechnology
End of Day: 17 April 2024 GMT-4
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Address
614 McKinley Place N.E.
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Kim Kelderman
CEO/COO/Director
Dr. Matthew McManus
President, Divisional
Mr. John L. Higgins
Director
Dr. Joseph D. Keegan, PhD
Director
Dr. Randolph C. Steer,M.D.,PhD
Director
Mr. Robert V. Baumgartner, C.P.A.
Chairman of the Board/Director
Dr. Roeland Nusse,PhD
Director
Ms. Julie L. Bushman
Director
Mr. James T. Hippel
CFO/Chief Accounting Officer/Executive VP
Dr. Rupert Vessey, B.M.,D.Phil.,F.R.C.P.,M.A.
Director
Dr. Alpna Seth, PhD
Director
Mr. William Geist
President, Divisional
Mr. Shane Bohnen
General Counsel/Secretary/Senior VP
Ownership
Institution Holdings
Vanguard Group Inc
18,228,210 (11.596%)
BlackRock Inc
18,133,912 (11.536%)
State Street Corporation
6,328,129 (4.026%)
BlackRock Fund Advisors
5,943,090 (3.781%)
BAMCO Inc
5,352,006 (3.405%)
Vanguard Investments Australia Ltd
5,058,310 (3.218%)
Baron Capital Management Inc
4,585,169 (2.917%)
Select Equity Group LP
4,559,173 (2.900%)
Fidelity Management & Research Company LLC
4,212,368 (2.680%)
Morgan Stanley - Brokerage Accounts
4,088,095 (2.601%)
Funds Holdings
Vanguard Total Stock Market Index Fund
4,975,142 (3.165%)
Vanguard US Total Market Shares ETF
4,975,142 (3.165%)
Vanguard Small Cap Index
4,038,663 (2.569%)
Vanguard Institutional 500 Index Trust
3,909,040 (2.487%)
Baron Growth Fund
2,930,000 (1.864%)
Baron Small Cap Growth Strategy
2,930,000 (1.864%)
Champlain Mid Cap Fund, LLC
2,724,984 (1.734%)
Neuberger Berman Genesis Fund
2,345,060 (1.492%)
Vanguard Small Cap Growth Index Fund
2,252,263 (1.433%)
Fidelity 500 Index Fund
1,877,679 (1.195%)
Make Smart Investment Choices